Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Biologists uncover pivotal role of a gene called "Cut"

Biologists uncover pivotal role of a gene called "Cut"

Combining fMRI and PET scanning creates a way to compare different measurements of the brain's function concurrently

Combining fMRI and PET scanning creates a way to compare different measurements of the brain's function concurrently

Aging may intensify and prolong feeling run down when common infections like the flu occur

Aging may intensify and prolong feeling run down when common infections like the flu occur

Natural cancer killing cells from the human embryonic stem cells

Natural cancer killing cells from the human embryonic stem cells

Obesity linked to dementia and Alzheimer's disease

Obesity linked to dementia and Alzheimer's disease

New way to measure the impact of AIDS on the living brain

New way to measure the impact of AIDS on the living brain

Fear of falling gait

Fear of falling gait

Specific gene on chromosome 15 regulates inflammation

Specific gene on chromosome 15 regulates inflammation

Osmolyte findings could have implications for the study of Alzheimer's disease, cystic fibrosis, kidney disease

Osmolyte findings could have implications for the study of Alzheimer's disease, cystic fibrosis, kidney disease

Gut antibody could prove to be a promising drug target for Crohn's disease

Gut antibody could prove to be a promising drug target for Crohn's disease

Earliest signs of Alzheimer's can be screened for with an electroencephalograph

Earliest signs of Alzheimer's can be screened for with an electroencephalograph

PET imaging with FDG represents one of the most promising tools for diagnosis of Alzheimer's

PET imaging with FDG represents one of the most promising tools for diagnosis of Alzheimer's

Divalent metal transporter-1 decreases metal-related injury in the lung

Divalent metal transporter-1 decreases metal-related injury in the lung

Landmark study aims to find genetic link to Alzheimer's disease

Landmark study aims to find genetic link to Alzheimer's disease

Researchers have successfully combined computer modeling and experimental results in folding studies for small proteins

Researchers have successfully combined computer modeling and experimental results in folding studies for small proteins

Potential beneficial effect of copper orotate

Potential beneficial effect of copper orotate

Loss of body mass over time appears to be strongly linked to older adults' risk of developing Alzheimer's disease

Loss of body mass over time appears to be strongly linked to older adults' risk of developing Alzheimer's disease

Tests of cognitive function are the best way so far to predict whether healthy elderly people will develop Alzheimer's

Tests of cognitive function are the best way so far to predict whether healthy elderly people will develop Alzheimer's

Scientists reverse memory loss in mice with Alzheimer's

Scientists reverse memory loss in mice with Alzheimer's

Notch1 and Jagged1 genes are likely markers indicating a patient's probable aggressive breast cancer

Notch1 and Jagged1 genes are likely markers indicating a patient's probable aggressive breast cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.